conatumumab
oleclumab
panitumumab
mapatumumab
drozitumab
patritumab
lintuzumab
matuzumab
onartuzumab
naptumomab estafenatox
tenatumomab
lexatumumab
duligotuzumab
inotuzumab
sibrotuzumab
inotuzumab ozogamicin
dacetuzumab
tigatuzumab
nofetumomab
figitumumab
dalotuzumab
lucatumumab
pamrevlumab
acrixolimab
adecatumumab
iratumumab
teprotumumab
pritumumab
avelumab
agonistic monoclonal antibody
durvalumab
ocrelizumab
sonepcizumab
tucotuzumab
elotuzumab
samalizumab
carlumab
brentuximab
apolizumab
ravulizumab
tislelizumab
gevokizumab
cergutuzumab
brolucizumab
pidilizumab
abagovomab
olaratumab
ipilimumab
intetumumab
bivatuzumab